title: Summary of the Standards, Options and Recommendations for the management of patients with nonmetastatic prostate cancer (2001).
authors.affiliation: CHRU Hôpital Huriez, Lille, France.
authors.forename: A
authors.initials: A
authors.lastname: Villers
authors.forename: P
authors.initials: P
authors.lastname: Pommier
authors.forename: A
authors.initials: A
authors.lastname: Bataillard
authors.forename: B
authors.initials: B
authors.lastname: Fervers
authors.forename: J M
authors.initials: JM
authors.lastname: Bachaud
authors.forename: N
authors.initials: N
authors.lastname: Berger
authors.forename: A F
authors.initials: AF
authors.lastname: Bertrand
authors.forename: R
authors.initials: R
authors.lastname: Bouvier
authors.forename: D
authors.initials: D
authors.lastname: Brune
authors.forename: A
authors.initials: A
authors.lastname: Daver
authors.forename: E
authors.initials: E
authors.lastname: Fontaine
authors.forename: O
authors.initials: O
authors.lastname: Haillot
authors.forename: J L
authors.initials: JL
authors.lastname: Lagrange
authors.forename: V
authors.initials: V
authors.lastname: Molinie
authors.forename: J P
authors.initials: JP
authors.lastname: Muratet
authors.forename: P
authors.initials: P
authors.lastname: Pabot du Chatelard
authors.forename: M
authors.initials: M
authors.lastname: Peneau
authors.forename: D
authors.initials: D
authors.lastname: Prapotnich
authors.forename: V
authors.initials: V
authors.lastname: Ravery
authors.forename: P
authors.initials: P
authors.lastname: Richaud
authors.forename: D
authors.initials: D
authors.lastname: Rossi
authors.forename: M
authors.initials: M
authors.lastname: Soulie
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use; D003131:Combined Modality Therapy; D003663:Decision Trees; D018450:Disease Progression; D006287:Health Planning Guidelines; D006801:Humans; D008017:Life Expectancy; D008297:Male; D009362:Neoplasm Metastasis; D011379:Prognosis; D011467:Prostate / Q000473:pathology*; D017430:Prostate-Specific Antigen / Q000097:blood; D011471:Prostatic Neoplasms / Q000097:blood / Q000473:pathology / Q000601:surgery / Q000628:therapy*; D011878:Radiotherapy; D012015:Reference Standards; D012106:Research; D016896:Treatment Outcome
chemical_list: D000970:Antineoplastic Agents; D017430:Prostate-Specific Antigen